Vimarsana
Biggest News Aggregation in the World

Page 9 - Evaluate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluate Pharma Today - Breaking & Trending Today

2023's Market Outlook For Cell And Gene Therapies - Vimarsana News

2023's Market Outlook For Cell And Gene Therapies

This article discusses quantifiable market trends, clinical developments, regulatory landscape analysis, and investment trends for cell and gene...

Private Equity Acquires A Taste For Drug Development - Vimarsana News

Private Equity Acquires A Taste For Drug Development

Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated funds and coming up with deals that compensate

Private equity acquires a taste for drug development - Vimarsana News

Private equity acquires a taste for drug development

By David Carnevali (Reuters) - Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in ...

Source: whbl.com
9 Best Value Stocks to Buy Now - Vimarsana News

9 Best Value Stocks to Buy Now

A roller-coaster year has sent a lot of deserving names into bargain territory. Here are nine value stocks for investors to consider as we head into 2023.

Evaluate Forecasts Pharmaceutical Market to be Worth $1.6tn in 2028 - Vimarsana News

Evaluate Forecasts Pharmaceutical Market to be Worth $1.6tn in 2028

New World Preview report finds strong top-line growth as pricing and patent headwinds build London, UK and Boston, MA – 18 October 2022: The global pharmaceutical industry is set to see sales grow by an annualised 6% between 2022 and 2028, according to the latest World Preview published by Evaluate Ltd...